Nearly every genetic disorder traces back to a change in DNA, the set of instructions inside nearly every cell. Some of these changes are passed down from parents, but many appear for the first time in a child with no family history. Having a disease-linked change doesn’t always mean getting sick, and the same change can be mild in one person and severe in another.1MedlinePlus. What are reduced penetrance and variable expressivity? Treatment has long meant managing symptoms, but for a small and growing list of conditions it now means correcting the underlying genetic problem.
What Goes Wrong in the DNA
Genes are written in a four-letter chemical code. A change in that code is called a mutation, though reports and doctors often call it a variant. The smallest kind changes just one letter, and sickle cell disease comes from exactly that kind of single-letter change.2Nature Education. Genetic Mutation One wrong letter can make a protein that works poorly or not at all, and that is enough to cause lifelong disease.
Genes are packaged into 46 chromosomes, 23 from each parent. Whole stretches of a chromosome can be deleted, duplicated, flipped, or moved to a different chromosome.3Nature Education. Genetic Mutation A person can then end up missing genes entirely or carrying too many copies of them.4Nature Education. Genetic Mutation Losing or doubling large areas is called a copy number change, and a chromosome change can affect dozens of genes at once, which is why chromosome conditions often touch many body systems.5Nature Education. Genetic Mutation
An embryo can also get one chromosome too many or too few.6PubMed Central. Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements This happens when chromosomes fail to separate properly, or separate too early, as the egg or sperm forms, so every cell in the resulting embryo carries the same error.7PubMed Central. Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements Down syndrome is the familiar example: it comes from an extra copy of chromosome 21 and typically isn’t inherited in the family sense.
Some rearrangements only reorder chromosome pieces without losing or adding any. The person carrying one may be healthy yet have trouble passing on a balanced set.8PubMed Central. Preimplantation Genetic Testing for Chromosomal Abnormalities: Aneuploidy, Mosaicism, and Structural Rearrangements
Finally, for a small set of genes, only the copy from one particular parent is meant to be active.9PubMed. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact When that on-off marking goes wrong, it can cause neurological, developmental, and metabolic disorders.10PubMed Central. Role of DNA methylation in imprinting disorders: an updated review These errors sometimes have no visible cause in the DNA sequence itself.11PubMed. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact
How Genetic Disorders Run in Families
You carry two copies of most genes, one from each parent. In an autosomal dominant disorder, one altered copy is enough to cause the condition.12MedlinePlus Genetics. What are the different ways a genetic condition can be inherited? A parent with a dominant condition therefore has a 1 in 2 chance of passing it to each child. In an autosomal recessive disorder, both copies must be altered.13MedlinePlus Genetics. What are the different ways a genetic condition can be inherited? Two healthy carriers, each with one altered copy, have a 1 in 4 chance with each pregnancy of having an affected child. Those odds apply fresh to every pregnancy. In recessive conditions, an unaffected sibling of an affected child has a 2 in 3 chance of being a carrier.
Most carriers of recessive conditions are healthy and have no idea. Everyone carries several recessive changes. Carrier screening before or early in pregnancy can show whether both partners carry the same condition.
Doctors work out the pattern in a family by mapping who was affected across generations.14Nature Education. Mendelian Genetics: Patterns of Inheritance and Single-Gene Disorders Dominant conditions tend to appear in every generation, while recessive ones can skip generations. Bringing details about relatives’ health and causes of death to a genetics appointment helps a lot.
Some disorders come from gene changes on the X chromosome and can be dominant or recessive.15MedlinePlus Genetics. What are the different ways a genetic condition can be inherited? Males have one X and females have two, so X-linked recessive conditions such as hemophilia mostly affect boys. A mother who carries the change has a 1 in 2 chance of passing it to each son.
Mitochondria, the cell’s energy producers, have their own small set of DNA, which is inherited only from the mother.16PubMed Central. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease Each cell holds thousands of copies of it, and it changes more readily than the main DNA.17PubMed Central. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease A cell can hold a mix of normal and altered copies, which helps explain why siblings with the same mitochondrial condition can be affected very differently.18PubMed Central. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease Changes in mitochondrial DNA have also been linked to diabetes and obesity.19PubMed Central. Maternal transmission of mitochondrial diseases
Some people with a disease-linked gene change never develop the condition.20MedlinePlus. What are reduced penetrance and variable expressivity? Other genes, environment, and lifestyle all play a part, though most of these factors are still unknown.21MedlinePlus. What are reduced penetrance and variable expressivity?
Common conditions like heart disease and type 2 diabetes aren’t caused by one gene but by thousands of small variations, each nudging risk slightly.22PubMed Central. Polygenic scores in biomedical research Some tests add these up into a polygenic risk score, which is an estimate of inherited tendency rather than a diagnosis.23PubMed Central. Polygenic scores in biomedical research
When a Disorder Appears Out of Nowhere
A de novo mutation appears for the first time in a child and isn’t inherited from either parent’s body cells. About 80% of these new changes come from the father’s side.24PubMed Central. New insights into the generation and role of de novo mutations in health and disease Sperm-making cells keep dividing throughout a man’s life and pick up copying errors each time,25PubMed Central. The impact of paternal age on new mutations and disease in the next generation so a child gains about 1 to 2 more new mutations for each extra year of the father’s age.26PubMed Central. The impact of paternal age on new mutations and disease in the next generation
Compared with a 25-year-old father, children of a 45-year-old father have roughly a 10% to 20% higher risk of conditions like autism, schizophrenia, or intellectual disability from these new mutations.27PubMed Central. Paternal-age-related de novo mutations and risk for five disorders Because these conditions are uncommon, a condition with a 1% baseline risk would rise only to about 1.2%.28PubMed Central. Paternal-age-related de novo mutations and risk for five disorders
Parents often wonder whether something they did caused it. New mutations are random copying errors, not caused by diet, stress, or behavior in pregnancy.
If a child’s condition came from a new mutation, the parents’ chance of a second affected child is usually low. The exception is a parent whose sperm or egg cells are mosaic, which can raise that chance. The affected child can still pass the change to their own children.
A mutation can also arise after conception, leaving the person a mosaic, with some cells carrying the change and others not.29PubMed Central. Disorders Caused by Genetic Mosaicism This has been found to cause many disorders, especially some skin-and-nerve conditions and developmental syndromes.30PubMed Central. Disorders Caused by Genetic Mosaicism Mosaic changes are often hidden but can sometimes cause major effects.31PubMed. Mechanisms and consequences of somatic mosaicism in humans
How Genetic Disorders Are Diagnosed
A karyotype photographs the chromosomes under a microscope and catches large changes like an extra chromosome. A chromosomal microarray finds smaller missing or extra pieces too tiny to see. Exome sequencing reads the protein-making parts of about 20,000 genes, catching single-letter changes.
The more detailed tests find a cause more often. In pregnancies where the baby was growing poorly, karyotyping found a cause in about 3%, a microarray in about 9%, and exome sequencing in about 25%.32PubMed Central. Whole-exome sequencing increases variant detection compared to karyotyping and CMA in an unselected FGR cohort Exome sequencing also found a cause in about 16% of these babies whose other two tests were normal.33PubMed Central. Whole-exome sequencing increases variant detection compared to karyotyping and CMA in an unselected FGR cohort A normal chromosome test, then, doesn’t rule out a genetic cause. Newer sequencing can now find everything from single-letter changes to large rearrangements in one test, speeding up diagnosis.34PubMed Central. A brief history of human disease genetics
Noninvasive prenatal testing uses a blood sample from the mother to screen for chromosome conditions such as extra chromosomes. A screen like this estimates likelihood; it doesn’t confirm a diagnosis. Diagnostic tests such as amniocentesis sample the baby’s own cells and give a firmer answer, but they carry a small procedure risk, which is why screens come first.
During IVF, embryos can be tested for extra or missing chromosomes before transfer.35PubMed Central. The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing Even so, after both a normal embryo test and a normal prenatal blood test, a baby with Down syndrome has been born.36PubMed Central. The limits of genetic screening: trisomy 21 after euploid preimplantation genetic testing for aneuploidy and negative noninvasive prenatal testing
A genetic counselor explains what a result means for you and your relatives, including uncertain results. They also help decide which test fits the situation and what it can and can’t show. Ask for one after a new diagnosis, with a family history, or when a result is unclear.
Reports may label a change “of uncertain significance,” meaning experts can’t yet say whether it causes disease. Such a result shouldn’t drive major decisions on its own. Labs may reclassify it later, so it’s worth checking back.
Treatments That Manage the Disorder
In phenylketonuria (PKU), the body can’t break down phenylalanine, a building block found in protein foods. Newborn screening catches it, and a low-phenylalanine diet with special formula starts within the first weeks of life.37PubMed Central. Phenylketonuria: a review of current and future treatments Children treated early avoid the intellectual disability PKU otherwise causes.38PubMed Central. Phenylketonuria: a review of current and future treatments The diet must be followed for life to prevent nerve damage.39PubMed Central. Nutritional Management of Phenylketonuria Many people struggle to keep to it because of the taste, and lapses are linked to poorer thinking and focus.40PubMed Central. Phenylketonuria: a review of current and future treatments The diet can also cause low vitamin D and B12.41PubMed Central. Phenylketonuria: a review of current and future treatments
For some storage diseases, where a missing enzyme lets waste build up in cells, the enzyme can be given by regular infusion.42PubMed. Enzyme replacement therapy for lysosomal storage diseases The body sometimes makes antibodies against the infused enzyme, which can weaken it.43PubMed. Enzyme replacement therapy for lysosomal storage diseases The enzyme also struggles to reach the brain and bones, which these diseases often damage.44PubMed. Enzyme replacement therapy for lysosomal storage diseases
Because none of this fixes the gene, treatment is lifelong. Regular blood tests check whether levels stay in a safe range, and infusions often mean hospital visits every week or two.
When no targeted treatment exists, most genetic disorders are treated by managing complications, with physical therapy, surgery, or medicines for specific symptoms. Specialist centers coordinate care across the many doctors a child may need.
Gene Therapy and Gene Editing
Gene therapy delivers a working copy of a gene into the body’s cells. For spinal muscular atrophy (SMA), which destroys the nerves that control muscles, Zolgensma uses a harmless modified virus to carry a working gene to those nerve cells.45PubMed. Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy It’s given once, as an infusion into a vein.46PubMed. Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy
Another SMA drug, nusinersen (Spinraza), approved in 2016, works on a backup gene people with SMA still have.47PubMed. Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review It changes how that backup gene’s message is processed so it makes more working protein,48PubMed Central. Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy and it’s injected into the fluid around the spinal cord.49PubMed Central. Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy It has improved movement in infants and children and lowered the chance that babies treated before symptoms will need a breathing machine.50PubMed Central. The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy Nerve cells lost to SMA don’t grow back, so treating before symptoms gives the best results, and newborn screening in many places allows treatment in the first weeks.
Casgevy, the first approved treatment using the CRISPR gene-editing tool, treats sickle cell disease in people 12 and older with repeated pain crises.51PubMed Central. Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease Doctors collect the patient’s blood-forming stem cells, edit them in a lab, and return them in a single infusion.52PubMed Central. Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia The edit switches back on the fetal form of hemoglobin, which doesn’t sickle.53PubMed Central. Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease In a trial, about 94% of patients went at least a year without a severe pain crisis.54PubMed Central. CRISPR/Cas9 in the treatment of sickle cell disease (SCD) and its comparison with traditional treatment approaches: a review Another approved one-time treatment for sickle cell disease, Lyfgenia, is a gene therapy that adds a modified hemoglobin gene rather than editing one.55PubMed Central. Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia
Getting there takes effort. Stem cells are collected from the patient’s blood over one or more sessions, and strong chemotherapy clears the bone marrow before the edited cells are returned. The process involves weeks in the hospital and months of recovery.
A one-time treatment may last for years, but long-term durability is still being followed. Edited body cells aren’t passed on, so children can still inherit the original gene change. It’s worth asking doctors what follow-up and long-term monitoring are needed.
Several hurdles remain. Getting genetic tools into the right cells is still hard, especially outside the liver.56PubMed Central. Delivering the future of immunotherapy: A state-of-the-art review of gene editing in immune cells with lipid nanoparticles The immune system can react against the delivery particles.57PubMed Central. Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung Treating before birth is being explored because it could prevent damage before it becomes permanent.58PubMed Central. Fetal gene therapy
Cost and Access to New Treatments
Fewer than 10% of rare diseases have an approved therapy at all.59ELSIhub Collections. Paying for Cures: The Ethics and Economics of Gene Therapies for Rare Diseases Gene therapies can cost €1 million to €2 million per patient, Zolgensma included.60PubMed Central. Disparities in access to gene therapy in the European Union: ethical and regulatory challenges Even wealthy countries’ health systems struggle to fund them, so whether a patient gets treated can depend on where they live and who pays.61PubMed Central. Disparities in access to gene therapy in the European Union: ethical and regulatory challenges
Gene-targeted treatments only work for a specific gene change, so the exact result matters. Without a confirmed diagnosis, families can’t qualify for therapies or trials, which is why detailed tests are worth pursuing when the first ones come back normal.
Ask the treating specialist about insurer approval, which often requires a confirmed genetic diagnosis. Patient advocacy groups for specific conditions often help with coverage and trials. Clinical trials can offer access to treatments not yet approved, and trial registries list them.